Cargando…

Comprehensive evaluation of the efficacy and safety of LPV/r drugs in the treatment of SARS and MERS to provide potential treatment options for COVID-19

Coronavirus disease 2019 (COVID-19) experienced an outbreak that expanded worldwide. Lopinavir/ritonavir (LPV/r), which is used effectively for severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronavirus infections, was applied for COVID-19 treatment given simila...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Liusheng, Zheng, Yuzhen, Liu, Jixian, Luo, Ruixing, Wu, Dingwang, Xu, Pengcheng, Wu, Da, Li, Xiaoqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8109137/ https://www.ncbi.nlm.nih.gov/pubmed/33879634 http://dx.doi.org/10.18632/aging.202860

Ejemplares similares

Long-chain noncoding ribonucleic acids affect the survival and prognosis of patients with esophageal adenocarcinoma through the autophagy pathway: construction of a prognostic model
por: Wu, Liusheng, et al.
Publicado: (2021)

Immunomodulatory Factor TIM3 of Cytolytic Active Genes Affected the Survival and Prognosis of Lung Adenocarcinoma Patients by Multi-Omics Analysis
por: Wu, Liusheng, et al.
Publicado: (2022)

Selective poly adenylation predicts the efficacy of immunotherapy in patients with lung adenocarcinoma by multiple omics research
por: Wu, Liusheng, et al.
Publicado: (2022)

CSF LPV concentrations and viral load in viral suppressed patients on LPV/r monotherapy given once daily
por: Tiraboschi, Juan, et al.
Publicado: (2014)

Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study
por: Deng, Lisi, et al.
Publicado: (2020)

Outcomes related to 4864 pregnancies with exposure to lopinavir/ritonavir (LPV/r)
por: Tookey, Pat, et al.
Publicado: (2014)

Status of coupling compensation for the LPv3 optics in 1995
por: Verdier, A
Publicado: (1995)

Efficacy and safety of lopinavir/ritonavir (LPV/r) in antiretroviral-experienced subjects infected with different subtypes of HIV-1
por: Maroldo, L, et al.
Publicado: (2010)

HIV Lipodystrophy in Participants Randomised to Lopinavir/Ritonavir (LPV/r) +2–3 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (N(t)RTI) or LPV/r + Raltegravir as Second-Line Antiretroviral Therapy
por: Martin, Allison, et al.
Publicado: (2013)

Understanding the acceptability and adherence to paediatric antiretroviral treatment in the new formulation of pellets (LPV/r): the protocol of a realist evaluation
por: Nebot Giralt, Ariadna, et al.
Publicado: (2017)

ARTEMIS: 192-week efficacy and safety of once-daily darunavir/ritonavir (DRV/r) vs lopinavir/r (LPV/r) in treatment-naïve HIV-1-infected adults
por: Orkin, C, et al.
Publicado: (2010)

Understanding acceptance of and adherence to a new formulation of paediatric antiretroviral treatment in the form of pellets (LPV/r)—A realist evaluation
por: Nebot Giralt, Ariadna, et al.
Publicado: (2019)

A deterministic approach for design of supervisory control of LPV systems with delay
por: Zahid, Ch. Nauman, et al.
Publicado: (2021)

Self-Scheduled LPV Control of Asymmetric Variable-Span Morphing UAV
por: Lee, Jihoon, et al.
Publicado: (2023)

Combination of long-acting HIV fusion inhibitor albuvirtide and LPV/r showed potent efficacy in HIV-1 patients
por: Zhang, Hongwei, et al.
Publicado: (2016)

Tumor Cell-Derived Exosomal miR-770 Inhibits M2 Macrophage Polarization via Targeting MAP3K1 to Inhibit the Invasion of Non-small Cell Lung Cancer Cells
por: Liu, Jixian, et al.
Publicado: (2021)

LPV modeling of nonlinear systems: A multi‐path feedback linearization approach
por: Abbas, Hossam S., et al.
Publicado: (2021)

Multiple Omics Analysis of the Role of RBM10 Gene Instability in Immune Regulation and Drug Sensitivity in Patients with Lung Adenocarcinoma (LUAD)
por: Wu, Liusheng, et al.
Publicado: (2023)

HRQoL improves in treatment-naïve HIV-1 subjects initiated on lopinavir/ritonavir (LPV/r) with raltegravir (RAL) or tenofovir/emtricitabine (TDF/FTC)
por: Baran, RW, et al.
Publicado: (2010)

LPV Control for the Full Region Operation of a Wind Turbine Integrated with Synchronous Generator
por: Cao, Guoyan, et al.
Publicado: (2015)

Pilot, Randomized Study Assessing Safety, Tolerability and Efficacy of Simplified LPV/r Maintenance Therapy in HIV Patients on the 1(st) PI-Based Regimen
por: Cahn, Pedro, et al.
Publicado: (2011)

Six-Year Immunologic Recovery and Virological Suppression of HIV Patients on LPV/r-Based Second-Line Antiretroviral Treatment: A Multi-Center Real-World Cohort Study in China
por: Huang, Xiaojie, et al.
Publicado: (2019)

A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus—A possible reference for coronavirus disease‐19 treatment option
por: Yao, Tian‐Tian, et al.
Publicado: (2020)

An LPV Adaptive Observer for Updating a Map Applied to an MAF Sensor in a Diesel Engine
por: Liu, Zhiyuan, et al.
Publicado: (2015)

Construction of a lung adenocarcinoma prognostic model based on N6-methyl-adenosine-related long noncoding RNA and screening of potential drugs based on this model
por: Hou, Qinghua, et al.
Publicado: (2022)

Efficacy and safety of current therapeutic options for COVID-19 - lessons to be learnt from SARS and MERS epidemic: A systematic review and meta-analysis
por: Zhong, Han, et al.
Publicado: (2020)

LPV Control and Virtual-Sensor-Based Fault Tolerant Strategies for a Three-Axis Gimbal System
por: Medero, Ariel, et al.
Publicado: (2022)

Meta-analysis and comprehensive study of coronavirus outbreaks: SARS, MERS and COVID-19
por: Berber, Engin, et al.
Publicado: (2021)

Is MERS another SARS?
por: Drosten, Christian
Publicado: (2013)

The search for therapeutic options for Middle East Respiratory Syndrome (MERS)
por: Arabi, Yaseen M., et al.
Publicado: (2016)

First-line therapy with LPV/r vs NVP and 2 NRTIs in a developing country: W144 of a randomized trial
por: Clumeck, Nathan, et al.
Publicado: (2014)

Pursuing use of optimal formulations for paediatric HIV epidemic control – a look at the use of LPV/r oral pellets and oral granules
por: Malati, Christine Y, et al.
Publicado: (2019)

A new LPV modeling approach using PCA-based parameter set mapping to design a PSS
por: Jabali, Mohammad B. Abolhasani, et al.
Publicado: (2017)

Randomized trial of DRV/r or LPV/r QD monotherapy vs maintaining a PI/r-based antiretroviral regimen in persons with suppressed HIV replication
por: Pinnetti, Carmela, et al.
Publicado: (2014)

Current treatment options and the role of peptides as potential therapeutic components for Middle East Respiratory Syndrome (MERS): A review
por: Mustafa, Sabeena, et al.
Publicado: (2018)

From SARS to MERS and Ebola
por: Yuen, Kwok Yung
Publicado: (2015)

Evolution of Framingham cardiovascular risk score in HIV-infected patients initiating EFV- and LPV/r-based HAART in a Latin American cohort
por: Cecchini, Diego, et al.
Publicado: (2014)

Comprehensive Review of Pulmonary Hypertension and Treatment Options in the Paediatric Population
por: Parmita, Pragyna D, et al.
Publicado: (2022)

Coronavirus vaccine development: from SARS and MERS to COVID-19
por: Li, Yen-Der, et al.
Publicado: (2020)

Reconsideration of interferon treatment for viral diseases: Lessons from SARS, MERS, and COVID-19
por: Ma, Dan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k2p05e54u7iorc43dpjn29nqio